Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 361

1.

Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndrome.

Olivier CB, Turakhia MP, Mahaffey KW.

Expert Opin Drug Saf. 2018 Mar;17(3):251-258. doi: 10.1080/14740338.2018.1424827. Epub 2018 Jan 24. Review.

PMID:
29363352
2.

[Bioresorbable scaffolds in the treatment of coronary artery disease. Expert consensus statement of the Association of Cardiovascular Interventions of the Polish Cardiac Society (ACVI PCS)].

Reczuch K, Milewski K, Wąsek W, Rzeszutko Ł, Wojakowski W, Hawranek M, Włodarczak A, Pawłowski T, Kochman J, Dobrzycki S, Grygier M, Ochała A, Wójcik J, Lesiak M, Dudek D, Legutko J.

Kardiol Pol. 2017;75(8):817-835. doi: 10.5603/KP.2017.0160. Polish.

PMID:
28819961
3.

Contemporary Atrial Fibrillation Management: A Comparison of the Current AHA/ACC/HRS, CCS, and ESC Guidelines.

Andrade JG, Macle L, Nattel S, Verma A, Cairns J.

Can J Cardiol. 2017 Aug;33(8):965-976. doi: 10.1016/j.cjca.2017.06.002. Epub 2017 Jun 9. Review.

PMID:
28754397
4.

The Surgical Treatment of Coronary Artery Occlusive Disease: Modern Treatment Strategies for an Age Old Problem.

Schwann TA.

Surg Clin North Am. 2017 Aug;97(4):835-865. doi: 10.1016/j.suc.2017.03.007. Review.

PMID:
28728719
5.

Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.

Pitts R, Daugherty SL, Tang F, Jones P, Ho PM, Tsai TT, Spertus J, Maddox TM.

Clin Cardiol. 2017 Jun;40(6):347-355. doi: 10.1002/clc.22686. Epub 2017 Apr 7.

6.

Meta-Analysis of the Optimal Percutaneous Revascularization Strategy in Patients With Acute Myocardial Infarction, Cardiogenic Shock, and Multivessel Coronary Artery Disease.

Tarantini G, D'Amico G, Tellaroli P, Colombo C, Brener SJ.

Am J Cardiol. 2017 May 15;119(10):1525-1531. doi: 10.1016/j.amjcard.2017.02.028. Epub 2017 Feb 28. Review.

PMID:
28341358
7.

Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds: A Review of the Published Data, Practical Recommendations, and Future Directions.

Capodanno D, Angiolillo DJ.

JACC Cardiovasc Interv. 2017 Mar 13;10(5):425-437. doi: 10.1016/j.jcin.2016.12.279. Review.

8.

Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study.

Goodman SG, Nicolau JC, Requena G, Maguire A, Blankenberg S, Chen JY, Granger CB, Grieve R, Pocock SJ, Simon T, Yasuda S, Vega AM, Brieger D; TIGRIS Study Investigators.

Int J Cardiol. 2017 Jun 1;236:54-60. doi: 10.1016/j.ijcard.2017.02.062. Epub 2017 Feb 21.

PMID:
28268087
10.

Revascularization Strategies and Outcomes in Elderly Patients With Multivessel Coronary Disease.

Posenau JT, Wojdyla DM, Shaw LK, Alexander KP, Ohman EM, Patel MR, Smith PK, Rao SV.

Ann Thorac Surg. 2017 Jul;104(1):107-115. doi: 10.1016/j.athoracsur.2016.10.053. Epub 2017 Jan 18.

PMID:
28109574
11.

Percutaneous revascularization of chronic total occlusions: Rationale, indications, techniques, and the cardiac surgeon's point of view.

Azzalini L, Torregrossa G, Puskas JD, Brilakis ES, Lombardi WL, Karmpaliotis D, Nakamura S, Colombo A, Carlino M.

Int J Cardiol. 2017 Mar 15;231:90-96. doi: 10.1016/j.ijcard.2017.01.026. Epub 2017 Jan 5. Review.

PMID:
28089148
12.

Moving Beyond SHOCK: New Paradigms in the Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock.

Kalavrouziotis D, Rodés-Cabau J, Mohammadi S.

Can J Cardiol. 2017 Jan;33(1):36-43. doi: 10.1016/j.cjca.2016.10.018. Epub 2016 Oct 24. Review.

PMID:
28024554
13.
14.

Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.

Tanaka A, Jabbour RJ, Latib A, Colombo A.

Catheter Cardiovasc Interv. 2016 Nov;88(S1):10-20. doi: 10.1002/ccd.26812.

PMID:
27797460
15.

Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) Registry.

Hira RS, Bhatt DL, Fonarow GC, Heidenreich PA, Ju C, Virani SS, Bozkurt B, Petersen LA, Hernandez AF, Schwamm LH, Eapen ZJ, Albert MA, Liang L, Matsouaka RA, Peterson ED, Jneid H.

J Am Heart Assoc. 2016 Oct 6;5(10). pii: e004113.

16.

The impact of recommended percutaneous coronary intervention care on hospital outcomes for interhospital-transferred STEMI patients.

Choi Y, Lee YJ, Shin SD, Song KJ, Lee K, Lee EJ, Kim YJ, Ahn KO, Hong KJ, Ro YS.

Am J Emerg Med. 2017 Jan;35(1):7-12. doi: 10.1016/j.ajem.2016.09.024. Epub 2016 Sep 16.

PMID:
27771225
17.

[Chronic coronary occlusions : When and how should revascularization be performed?]

Mashayekhi K, Büttner HJ.

Herz. 2016 Nov;41(7):585-590. Review. German.

PMID:
27484494
18.

Meta-Analysis Comparing Complete Revascularization Versus Infarct-Related Only Strategies for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease.

Shah R, Berzingi C, Mumtaz M, Jasper JB, Goswami R, Morsy MS, Ramanathan KB, Rao SV.

Am J Cardiol. 2016 Nov 15;118(10):1466-1472. doi: 10.1016/j.amjcard.2016.08.009. Epub 2016 Aug 23. Review.

PMID:
27642115
19.

Left Main Coronary Artery Disease: Secular Trends in Patient Characteristics, Treatments, and Outcomes.

Lee PH, Ahn JM, Chang M, Baek S, Yoon SH, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Park DW, Park SJ.

J Am Coll Cardiol. 2016 Sep 13;68(11):1233-1246. doi: 10.1016/j.jacc.2016.05.089. Review.

20.

[Japanese guidelines for elective percutaneous coronary intervention in patients with stable coronary disease].

Fukuhara R, Fujiwara H.

Nihon Rinsho. 2016 Jun 20;74 Suppl 4 Pt 1:347-52. Japanese. No abstract available.

PMID:
27534194

Supplemental Content

Loading ...
Support Center